MAYZENT®
Indications
Mayzent is indicated for the treatment of adult patients with secondary progressive multiple sclerosis (SPMS) with active disease evidenced by relapses or imaging features of inflammatory activity.
MAYZENT®
Rate this content:
No votes yet
SG2311060355, FA-11236876, FA-11236884